MedTrace Logo

Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp

NCT05336682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-02-27

No results posted yet for this study

Summary

Group I (Experimental group I): Lesion Sterilization and Tissue Repair with radicular instrumentation.

Coronal and accessible radicular pulp tissue are extirpated using rotary files. After proper drying, the paste is placed in the cavity and canals.

Group II (Experimental group II): Lesion Sterilization and Tissue Repair with no radicular instrumentation.

Only the coronal pulp is removed, the pulpal floor is covered with triple antibiotic paste with propylene glycol mix.

Group III (Control group): Conventional pulpectomy. Pulp tissue extirpation is done. Biomechanical preparation is done using rotary files with frequent irrigation with Chlorhexidine. The canals are dried using sterile absorbent paper points followed by obturation by the paste of Zinc oxide and eugenol.

Conditions

  • Pulpitis - Irreversible

Interventions

PROCEDURE

Lesion Sterilization and Tissue Repair with radicular instrumentation

Coronal and accessible radicular pulp tissue are extirpated using rotary files. After proper drying, the paste is placed in the cavity and the canals.

PROCEDURE

Lesion Sterilization and Tissue Repair without radicular instrumentation

Only the coronal pulp is removed, the pulpal floor is covered with triple antibiotic paste with propylene glycol mix.

PROCEDURE

Conventional pulpectomy

Pulp tissue extirpation is done. Biomechanical preparation is done using rotary files with frequent irrigation with Chlorhexidine. The canals are dried using sterile absorbent paper points followed by obturation by the paste of ZOE.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Gihan M Abuelniel, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-20
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05336682 on ClinicalTrials.gov